Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
100
datasets available to search
ShareScore release 0.9.0
Dataset results
100 results for “NMIBC”
LEGEND Study: EG-70 in NMIBC Patients BCG-Unresponsive and High-Risk NMIBC Incompletely Treated With BCG or BCG-Naïve
ClinicalTrials.gov study NCT04752722. IPD Sharing: NO. Countries: 10. Publications: 0.
A Study of T3011 in Patients With BCG-Unresponsive NMIBC or BCG-Exposed, Chemotherapy-Unresponsive NMIBC
ClinicalTrials.gov study NCT06971614. IPD Sharing: NO. Countries: 1. Publications: 0.
Study to Evaluate the Efficacy and Safety Of Intravesical Nanoxel®M In BCG Refractory NMIBC
ClinicalTrials.gov study NCT02982395. IPD Sharing: NO. Countries: 1. Publications: 0.
Testing the Addition of an Anti-Cancer Drug, Gemcitabine, to Usual Treatment (BCG Alone) in People Whose Non-Muscle Invasive Bladder Cancer (NMIBC) Came Back After Prior BCG Therapy
ClinicalTrials.gov study NCT07000084. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Hyaluronic Acid Sodium Salt and Hydeal-D in the Management of LUTS After TURBT for NMIBC.
ClinicalTrials.gov study NCT06069453. IPD Sharing: NO. Countries: 1. Publications: 0.
Safety and Efficacy Study of Tislelizumab in Combination With BCG in HR-NMIBC Patients (TACBIN-01)
ClinicalTrials.gov study NCT04922047. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
A Prospective Registry to Assess the Effectiveness and Local Tolerability of Intravesical Valrubicin in Subjects With Non-muscle Invasive Bladder Cancer (NMIBC)
ClinicalTrials.gov study NCT01314664. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Storz Professional Image Enhancement System Versus White Light Imaging Assisted TURBT for Treatment of NMIBC
ClinicalTrials.gov study NCT03138824. IPD Sharing: YES. Countries: 1. Publications: 0.
Assessement of the Concordance of Genomic Alterations Between Urine and Tissue in High-Risk NMIBC Patients
ClinicalTrials.gov study NCT04412070. IPD Sharing: NO. Countries: 1. Publications: 0.
A Study of Intravesical Enfortumab Vedotin For Treatment of Patients With Non-muscle Invasive Bladder Cancer (NMIBC)
ClinicalTrials.gov study NCT05014139. IPD Sharing: NO. Countries: 6. Publications: 0.
Intravesical Photodynamic Therapy (PDT) in BCG Refractory High-Risk Non-muscle Invasive Bladder Cancer (NMIBC) Patients
ClinicalTrials.gov study NCT03053635. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Investigating the Efficacy and Safety of Neoadjuvant Intravesical Instillation of Mitomycin C in Treating High-risk NMIBC Patients
ClinicalTrials.gov study NCT06696794. IPD Sharing: YES. Countries: 1. Publications: 0.
Clinical Study of T3011 Intravesical Instillation for Treatment of NMIBC Patients
ClinicalTrials.gov study NCT06427291. IPD Sharing: NO. Countries: 1. Publications: 0.
BCG Modulation of the recMAGE-A3 + AS15 ASCI Response in the Treatment of Non Muscle Invasive Bladder Cancer (NMIBC) Patients
ClinicalTrials.gov study NCT01498172. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study of RAG-01 in Patients With Non-muscle-invasive Bladder Cancer (NMIBC) Who Have Failed Bacillus Calmette Guérin (BCG) Therapy
ClinicalTrials.gov study NCT06351904. IPD Sharing: NO. Countries: 1. Publications: 0.
A Study of SHR-1501 Alone or in Combination With BCG or SHR-1316 in Subjects With NMIBC
ClinicalTrials.gov study NCT05410730. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
DV+BCG in HER2-Expressing, BCG-Naïve High-Risk NMIBC
ClinicalTrials.gov study NCT07207824. IPD Sharing: NO. Countries: 1. Publications: 0.
Clinical Trial for Evaluating the Efficacy and Safety of BCG for Therapeutic Use in the Prevention of Postoperative Recurrence of Medium/High-risk Non-muscle Invasive Bladder Cancer (NMIBC)
ClinicalTrials.gov study NCT06241755. IPD Sharing: NO. Countries: 1. Publications: 0.
Safety and Efficacy of CG0070 Oncolytic Virus Regimen for High Grade NMIBC After BCG Failure
ClinicalTrials.gov study NCT02365818. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study of TAR-200 Versus Intravesical Chemotherapy in Participants With Recurrent High-Risk Non-Muscle-Invasive Bladder Cancer (HR-NMIBC) After Bacillus Calmette-Guérin (BCG)
ClinicalTrials.gov study NCT06211764. IPD Sharing: YES. Countries: 14. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.